Solid Biosciences, Inc. (SLDB)
5.82
+0.11
(+1.93%)
USD |
NASDAQ |
Dec 16, 16:00
6.00
+0.18
(+3.09%)
After-Hours: 05:21
Solid Biosciences Research and Development Expense (Annual): 96.43M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Iovance Biotherapeutics, Inc. | 282.34M |
| Travere Therapeutics, Inc. | 217.50M |
| Xenetic Biosciences, Inc. | 2.584M |
| KalVista Pharmaceuticals, Inc. | 76.72M |
| BeyondSpring, Inc. | 2.644M |